50 search results for “immunology” in the Staff website
-
Robin van den BiggelaarFaculty of Science
-
Sander van KasterenFaculty of Science
-
Gideon KerstenFaculty of Science
-
Chemical Adventures in Immunology
Inaugural lecture
-
Madeline KavanaghFaculty of Science
-
Making the invisible visible with ‘click chemistry’
Sander van Kasteren (Professor of Molecular Immunology) makes the invisible visible. He will explain more in his inaugural lecture.
-
Saloni SaxenaFaculty of Science
-
‘Science isn’t about memorising a textbook’
How do you engage students? Sander van Kasteren knows how to do that like no other. ‘He compares immune cells to Pokémon and doesn’t just give information; he tells stories,’ students say about their favourite lecturer, Sander van Kasteren. The Professor of Molecular Immunology passionately teaches…
-
Berend GagesteinFaculty of Science
-
Alexandra VelthuijzenFaculty of Science
-
Yixuan WangFaculty of Science
-
Tijn Vleeshouwer
Faculty of Science
-
Eva George MatlalcuatziFaculty of Science
-
Thijmen Mostert
Faculty of Science
-
Amit CherianFaculty of Science
-
Twan Tjoa
Faculty of Science
-
Liesbeth van der VeldenFaculty of Science
-
Heleen PeetersFaculty of Science
-
Donja van den Beld
Faculty of Science
-
Yunfei Wu
Faculty of Science
-
Enebie Ramos CáceresFaculty of Science
-
Laura BogueFaculty of Science
-
Kas Steuten
Faculty of Science
-
Jessica Hoang
Faculty of Science
-
David LickoFaculty of Science
-
Lucas Moritz BickemFaculty of Science
-
Rocaya Ali
Faculty of Science
-
Luuk Reinalda
Faculty of Science
-
Benjamin BakkerFaculty of Science
-
Kim BongerFaculty of Science
-
Jessica van Krimpen-KraaijenoordFaculty of Science
-
Lucie DelfosFaculty of Science
-
Chemistry as the key to medical innovation
Is it a coincidence that three chemists from the same department have each independently received a ZonMw grant? 'No,' the researchers agree in unison. 'The role of chemistry in medical biology is becoming increasingly important, and we’ve worked hard to make this happen.'
-
Marco van Eijk new OD of Life Science & Technology
As of 1 September, Marco van Eijk has been appointed Director of Education of the bachelor's programme Life Science & Technology. He succeeds Marcellus Ubbink, who moved to the position of Scientific Director of the Leiden Institute for Chemical Research (LIC). Van Eijk has been appointed for a period…
-
Combating antibiotic resistance together
Antibiotic resistance is a common problem among patients. The European Project TIPAT trains pharmacologists, microbiologists and immunologists of six universities in interdisciplinary thinking. The ultimate goal is to develop better treatment guidelines to combat resistance. Coen van Hasselt of the…
-
Three Leiden researchers receive ERC Synergy Grant
Leiden researchers Arjen Doelman, Tom Huizinga and Manfred Wuhrer have been awarded ERC Synergy Grants worth millions of euros for their research on preventing tipping points being reached in ecosystems and helping eradicate rheumatism.
-
Spotlight on girls in Science: RISE lanceert jongerenraad
On the International Day of Women and Girls in Science (11 February) RISE puts the spotlight on four women in our faculty. The Researchers in Science for Equality (RISE) network is launching a junior board on this special day. Their main task? Optimise the information provision between RISE and the…
-
Video series: Why Latin America matters
Latin America matters! With its rich history, culture, its impressive resilience and creative innovation in the face of such a diverse array of challenges, Latin America can indeed show the way forward inspiring for positive change. Working together with Latin American institutions, our researchers…
-
Hermen OverkleeftFaculty of Science
-
Vidi grant for seven researchers from Leiden University
From malaria parasites as a vaccine to how top-level bureaucrats reach their decisions: seven researchers from Leiden University have received a Vidi grant from the Dutch Research Council (NWO). This 800,000-euro grant will enable them to develop their own innovative line of research over the next five…
-
Preventing heart attacks by earlier detection of cardiovascular disease
In the Netherlands, 1.55 million people suffer from cardiovascular diseases. Yet, acute cardiovascular events, such as a heart attack or stroke, often occur unexpectedly. That is because many people do not know they are at risk for such an event. Immunological researcher Amanda Foks and her colleagues…
-
Stiffness and viscosity of cells differ in cancer and other diseases
During illness, the stiffness or viscosity of cells can change. Tom Evers demonstrated this by measuring such properties of human immune cells for the first time. ‘The stiffness of certain cells could be a way to make a diagnosis,’ Evers said. He defended his thesis on March 26th.
-
Vidi grants for eight researchers from Leiden University
Eight scientists from Leiden University have been awarded a grant by the Dutch Research Council (NWO). With this Vidi funding, the researchers can set up an innovative line of research and further expand their own research group over the next five years.
-
3D-printed mini-tumours: a leap forward in improving cancer immunotherapy
Leiden researchers have developed a groundbreaking model to advance cancer immunotherapy. Using a 3D printer, they create mini-tumors within an environment that closely mimics human tissue. They have also developed a method to monitor real-time interactions of these mini-tumours with immune cells during…
-
Spinoza and Stevin Prizes for three Leiden professors
Three Leiden professors have recently been awarded the most prestigious scientific accolade in the Netherlands: Maria Yazdanbakhsh and Marc Koper have been awarded a Spinoza Prize and Judi Mesman a Stevin Prize. They received their prizes on 13 October.
-
De dag van Jasper
Jasper Knoester is the dean of the Faculty of Science. How is he doing, what exactly does he do and what does his day look like? In each newsletter, Jasper gives an insight into his life. This time, Jasper writes his column from Singapore.
-
How Oncode-PACT is bringing new cancer medicines closer with 325 million in Growth Fund money
How can you ensure that more experimental drugs reach the finish line? At the moment, only one in twenty cancer drugs that are tested on humans makes it to the market. This is an enormous loss for patients and society. With a grant from the National Growth Fund, Oncode-PACT aims to efficiently select…
-
Is a cancer pill a matter of time?
A cancer pill, preferably without severe side effects, is something we’d all welcome. Is it a matter of time before such a pill is a reality? We put this question to three Leiden researchers and asked how they themselves are contributing to new cancer treatments.
-
Breaking the Cycle of Heart Attacks
Lecture, Tuesday Talk
-
Cancelled: Breaking the Cycle of Heart Attacks
Lecture, Tuesday Talks: Science Insights